Sign in Create account

Wanbury Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: WANBURY BSE: 524212
₹199.50
▼ -17.45 (-8.04%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
44/100
Moderate
Valuation
65/100
Fairly Valued
Momentum
25/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹697 Cr
PE (TTM)
11.5
Industry median 36.1 (152 companies)
Price to Book
11.8
PEG (TTM)
0.4
Institutions holding %
0.95%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
-29.0
Relative return vs Sector, qtr %
-30.6
Free Cash Flow
₹-28 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-77.43%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
41.85%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
3.63%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-75.96%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
1.47%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.19
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
1.49
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
2.67
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
1.96%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
7.59%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
12.44%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
7.43%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
28.35%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
26.64%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • No Debt to equity is below 0.5 (1.49)
  • Yes Return on equity is 15% or more (26.6%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (62.2% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-8.0%
Low 196.0500 · High 220.5500
1W return
-14.4%
Low 196.0500 · High 238.4000
1M return
-21.5%
Low 196.0500 · High 256.7000
52W return
-20.0%
Low 161.5000 · High 358.8500
Lifetime High ₹344.7500 (July 15, 2026)
Lifetime Low ₹11.1500 (Oct. 18, 2019)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
214.6
10D
221.0
20D
230.5
50D
249.3
100D
257.3
200D
254.5

Delivery and volume

Day avg. delivery
48.0%
Week avg. delivery
50.0%
Month avg. delivery
49.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

205.37
Pivot
First resistance214.68
Second resistance229.87
Third resistance239.18
First support190.18
Second support180.87
Third support165.68
Day RSI25.1
Day MFI18.6
Day MACD-12.38
Day MACD signal-11.37

Beta

1M2.44
3M0.71
1Y1.32
3Y1.19

Price change analysis

↓ -21.5%
Over 1 Month
LowHigh
196.05256.70
↓ -30.6%
Over 3 Months
LowHigh
196.05358.85
↓ -13.4%
Over 6 Months
LowHigh
196.05358.85
↓ -20.0%
Over 1 Year
LowHigh
161.50358.85
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 11.5 (own history: 10.8–51.9)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹166 Cr
Net profit (June 30, 2026)
₹3 Cr
Basic EPS (June 30, 2026)
₹0.9300

Ranks #99 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter43.02%
  • FII/FPI0.89%
  • Other DII0.06%
  • Public56.03%

Largest holders

NameCategoryShares %Shares
EXPERT CHEMICALS (INDIA) PVT LTDPromoter34.3600%12005561
KINGSBURY INVESTMENTS INCPromoter8.6500%3024000
SURESH BHATIAPublic3.1100%1087795
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDPublic2.0700%722865
ZAKI ABBAS NASSERPublic1.7600%615000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 43.02% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 0.59% to 0.89% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 5 insider trades, 15 SAST, 6 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
29 Jul 2025 SBICAP Trustee Company Limited Other Pledge Revoke 0 ₹28
17 May 2024 SBICAP Trustee Company Limited Other Pledge 0 ₹8.50 L
15 Apr 2024 SBICAP trustee Company Limited Other Pledge 0 ₹74.07 L
31 Aug 2023 SBICAP Trustee Company Limited Other Pledge 0 ₹5.93 Cr
25 Apr 2017 Expert Chemicals (India) Private Limited Promoter Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 60 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
31 Dec 2024 SURESH BHATIA Block Buy 352,421 283.7800 NSE
31 Dec 2024 BHATIA SURESH Block Sell 352,421 283.7800 NSE
31 Dec 2024 SURESH BHATIA Block Buy 352,421 283.7800 NSE
31 Dec 2024 BHATIA SURESH Block Sell 352,421 283.7800 NSE
27 May 2024 VIJAY KUNDANMAL CHORARIA Bulk Sell 599,000 148.0000 NSE
27 May 2024 SURBHI INVESTMENTS AND TRADING COMPANY PRIVATE LIMITED Bulk Buy 562,399 148.0000 NSE
20 Oct 2023 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 202,818 88.5000 NSE
4 May 2023 GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED Bulk Buy 219,753 52.7000 BSE
21 Apr 2023 RASHI FINCORP LIMITED Bulk Sell 196,000 38.0000 BSE
27 Jan 2022 EARC TRUST SC 145 Bulk Sell 1,750,000 77.2700 NSE

All bulk and block deals →

Dividends

Full dividend history →
Ex-dateSubjectPer share (₹)Record date
29 Jul 2010 Dividend-Rs.1/- Per Share 1.0000 —
12 Mar 2009 Agm/Dividend - 5% — —
13 Sep 2007 Agm/Dividend-20% — —

Corporate Actions

Full history (21 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
20 Sep 2024OTHERAnnual General Meeting
10 Nov 2023OTHERExtra Ordinary General Meeting
20 Sep 2023OTHERAnnual General Meeting
14 Aug 2023OTHERExtra-Ordinary General Meeting
20 Sep 2022OTHERAnnual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
11 Aug 2026 Financial Results Yes
29 May 2026 Financial Results Yes
14 May 2026 Financial Results Yes
5 Feb 2026 Financial Results Yes
13 Nov 2025 Financial Results Yes

Corporate Announcements

All 478 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Trading Window Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
29 Sep 2026 Insider Trading / SAST Wanbury Ltd - 524212 - Closure of Trading Window
25 Sep 2026 Shareholders meeting Wanbury Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
25 Sep 2026 AGM/EGM Wanbury Ltd - 524212 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
24 Sep 2026 Change in Management Wanbury Limited has informed the Exchange about change in Management
24 Sep 2026 Shareholders meeting Wanbury Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
2 Sep 2026 Copy of Newspaper Publication Wanbury Limited has informed the Exchange about Copy of Newspaper Publication: Information regarding 38th Annual General Meeting to be held through Video Conferencing (VC)/Other Audio Visual Means (OAVM).
31 Aug 2026 Record Date Wanbury Limited has informed the Exchange that Record date for the purpose of Meeting is 18-Sep-2026.
31 Aug 2026 Shareholders meeting Wanbury Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
28 Aug 2026 Copy of Newspaper Publication Wanbury Limited has informed the Exchange about Copy of Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (26.6%)

Weaknesses

  • Thin net profit margin (2.0%)
  • High financial leverage (Debt/Equity 1.49)
  • Declining profit YoY (-76.0%)

Opportunities

  • PEG below 1 (0.36) -- earnings growth outpacing its own valuation
  • PE below 15 (11.5) relative to a typical growth business
  • RSI in oversold territory (25.1) -- a technical rebound zone

Threats

  • Down 20.0% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Wanbury Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.